维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="Poluzzi E"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Antibacterial macrolides:a drugs class with a complex pharmacological profile显示文摘	Abu-Gharbieh E Vasina V Poluzzi E	2004	Pharmacol Res2004，50，：	1
2	Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes:an overview显示文摘	de Ponti F Poluzzi E Cavalli A	2002	Drug Saf2002，25，4：	1
3	Toward a pharmacophore for drugs inducing the lon QT syndrome 显示文摘	Cavalli A Poluzzi E De Ponti F	2002	J Med Chem2002，45，18：	1
4	Drug-induced torsades de pointes:data mining of the public version of the FDA Adverse Event Reporting System (AERS)显示文摘	Poluzzi E Raschi E Moretti U	2009	Pharmacoepidemiol Drug Saf2009，18，6：	1
5	QT-interval shortening in spontaneous reports submitted to the FDA:the need for consensus显示文摘	Raschi E Poluzzi E Koci A	2011	Br J Clin Pharmaco2011，72，5：	1
6	QT-interval prolongation bynon-cardiac drugs:lessons to be learned from recent experience显示文摘	De Ponti F Poluzzi E Montanaro N	2000	Eur J Clin Pharmacol2000，56，1：	1
7	QTc and psychotropic drugs显示文摘	De Ponti F Poluzzi E Montanaro N		0，，：	1
8	Montanoro N QT interval prolongadon by cardiac or noncardiac factors显示文摘	De Ponti F Poluzzi E	2002	Eur J Clin Pharmacol2002，57，1：	1
9	Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview显示文摘	De Ponti F Poluzzi E Cavalli A	2002	Drug Saf2002，25，4：	1
10	Antibacterial macrolides: a drug class with a complex pharmacological profile显示文摘	ABU-GHARBIEH E VASINA V POLUZZI E	2004	50(3 ) : 211-2222004，50，3：	1
11	Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsades de pointes:an overview显示文摘	De Pi F Poluzzi E Cavalli A	2002	Drug Saf2002，25，4：	1
12	QT-interval prolongation by non-cardiac drugs:lessons to be learned from recent experience显示文摘	De Ponti F Poluzzi E Montanaro N	2000	Eur J Clin Pharmacol2000，56，1：	1
13	Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers显示文摘	Cavalli A Poluzzi E De Ponti F	2002	J Med Chem2002，45，18：	1
14	QT interval prolongation by non-cardiac drugs: lessons to be learned from recent experience显示文摘	De Ponti F Poluzzi E Montanaro N	2000	Eur J Clin Pharmacol2000，56，1：	1
15	The hERG K+ channel: target and antitarget strategies in drugdevelopment显示文摘	RASCHI E VASINA V POLUZZI E	2008	Pharmacol Res2008，57，3：	1
16	The hERG K+ channel:target and antitarget strategies in drug development显示文摘	Rashi E Vasina V Poluzzi E	2008	Pharmacol Res2008，57，：	1
17	Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs:a call for consensus显示文摘	Ponti F Poluzzi E Montanaro N	2001	Eur J Clin Pharmacol2001，57，3：	1
18	Toward a pharmacophore for drugs inducing the long QT syndrome:insights from a CoMFA study of HERG K+ channel blockers显示文摘	Cavelli A Poluzzi E De Ponti F	2002	J Med Chem2002，45，18：	1
19	Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy显示文摘	Poluzzi E Strahinja P Lanzoni M	2008	Eur J Clin Pharmacol2008，64，4：	1
20	Safety of non-antiarrhythmie drugs that prolong the QT interval or induce torsade de pointes: an overview显示文摘	De Ponti F Poluzzi E Cavalli A	2002	Drug Saf2002，25，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示